106 related articles for article (PubMed ID: 26677712)
1. [Virtual screening for natural CETP inhibitors by structure-based pharmacophore].
Huo XQ; Qiao LS; Jiang LD; He YS; Li GY; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2015 Aug; 40(15):3063-7. PubMed ID: 26677712
[TBL] [Abstract][Full Text] [Related]
2. [Discovery of potential ATP-sensitive potassium channel openers with potential hypotensive activity from Chinese herbs based on molecular simulation].
Li Y; Jiang LD; Chen X; He YS; Li GY; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(2):264-271. PubMed ID: 28861972
[TBL] [Abstract][Full Text] [Related]
3. Potential Inhibitors of the Activity of the Cholesterol-Ester Transfer Protein.
Tárraga WA; Garda HA; Toledo JD; Gonzalez MC
J Comput Biol; 2019 Dec; 26(12):1458-1469. PubMed ID: 31356116
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubility.
Kalgutkar AS; Frederick KS; Hatch HL; Ambler CM; Perry DA; Garigipati RS; Chang GC; Lefker BA; Clark RW; Morehouse LA; Francone O; Hu X
Xenobiotica; 2014 Jul; 44(7):591-605. PubMed ID: 24380613
[TBL] [Abstract][Full Text] [Related]
5. Reliable structural information for rational design of benzoxazole type potential cholesteryl ester transfer protein (CETP) inhibitors through multiple validated modeling techniques.
Amin SA; Adhikari N; Gayen S; Jha T
J Biomol Struct Dyn; 2019 Oct; 37(17):4528-4541. PubMed ID: 30488780
[TBL] [Abstract][Full Text] [Related]
6. [Study on lipid-lowering traditional Chinese medicines based on pharmacophore technology and patent retrieval].
Huo XQ; He YS; Qiao LS; Sun ZY; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(24):4839-43. PubMed ID: 25898588
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of N,N-3-phenyl-3-benzylaminopropanamide derivatives as novel cholesteryl ester transfer protein inhibitor.
Zhao D; Xie H; Bai C; Liu C; Hao C; Zhao S; Yuan H; Luo C; Wang J; Lin B; Zheng J; Cheng M
Bioorg Med Chem; 2016 Apr; 24(8):1589-97. PubMed ID: 27010500
[TBL] [Abstract][Full Text] [Related]
8. Molecular Docking and Pharmacophore Modeling Studies of Fluorinated Benzamides as Potential CETP Inhibitors.
Khalaf RA; Al-Rawashdeh S; Sabbah D; Abu Sheikha G
Med Chem; 2017; 13(3):239-253. PubMed ID: 27823564
[TBL] [Abstract][Full Text] [Related]
9. Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration.
Abu Khalaf R; Abu Sheikha G; Bustanji Y; Taha MO
Eur J Med Chem; 2010 Apr; 45(4):1598-617. PubMed ID: 20116902
[TBL] [Abstract][Full Text] [Related]
10. [Discovery of potential LXRβ agonists from Chinese herbs using molecular simulation methods].
Luo GG; Lu F; Qiao LS; Li Y; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(16):3065-3071. PubMed ID: 28920350
[TBL] [Abstract][Full Text] [Related]
11. Virtual screening and drug design for PDE-5 receptor from traditional Chinese medicine database.
Chen CY
J Biomol Struct Dyn; 2010 Apr; 27(5):627-40. PubMed ID: 20085380
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Molecular Modeling and Biological Evaluation of Novel Trifluoromethyl Benzamides as Promising CETP Inhibitors.
Abu Khalaf R; Abusaad A; Al-Nawaiseh B; Sabbah D; Albadawi G
Curr Comput Aided Drug Des; 2024; 20(5):564-574. PubMed ID: 37165488
[TBL] [Abstract][Full Text] [Related]
13. A combination of pharmacophore modeling, molecular docking and virtual screening for iNOS inhibitors from Chinese herbs.
Wang X; Ren Z; He Y; Xiang Y; Zhang Y; Qiao Y
Biomed Mater Eng; 2014; 24(1):1315-22. PubMed ID: 24212027
[TBL] [Abstract][Full Text] [Related]
14. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
15. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport.
Bruce C; Chouinard RA; Tall AR
Annu Rev Nutr; 1998; 18():297-330. PubMed ID: 9706227
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and SAR studies of ursolic acid 3β-ester derivatives as novel CETP inhibitors.
Chen C; Sun R; Sun Y; Chen X; Li F; Wen X; Yuan H; Chen D
Bioorg Med Chem Lett; 2020 Jan; 30(2):126824. PubMed ID: 31780304
[TBL] [Abstract][Full Text] [Related]
17. Prediction Methods of Herbal Compounds in Chinese Medicinal Herbs.
Han K; Zhang L; Wang M; Zhang R; Wang C; Zhang C
Molecules; 2018 Sep; 23(9):. PubMed ID: 30201875
[TBL] [Abstract][Full Text] [Related]
18. Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.
Kappelle PJ; van Tol A; Wolffenbuttel BH; Dullaart RP
Cardiovasc Ther; 2011 Dec; 29(6):e89-99. PubMed ID: 20645987
[TBL] [Abstract][Full Text] [Related]
19. Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
Chen KC; Chang SS; Huang HJ; Lin TL; Wu YJ; Chen CY
J Biomol Struct Dyn; 2012; 30(6):662-83. PubMed ID: 22731403
[TBL] [Abstract][Full Text] [Related]
20. Structural and biophysical insight into cholesteryl ester-transfer protein.
Hall J; Qiu X
Biochem Soc Trans; 2011 Aug; 39(4):1000-5. PubMed ID: 21787337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
